Skip NavigationSkip to Content

Combing the Cancer Genome for Novel Kinase Drivers and New Therapeutic Targets

  1. Author:
    Torres-Ayuso,Pedro
    Brognard,John
  2. Author Address

    NCI, Lab Cell & Dev Signaling, Ctr Canc Res, Frederick, MD 21702 USA.
    1. Year: 2019
    2. Date: Dec
    3. Epub Date: 2019 12 07
  1. Journal: CANCERS
  2. MDPI,
    1. 11
    2. 12
  3. Type of Article: Review
  4. Article Number: 1972
  5. ISSN: 2072-6694
  1. Abstract:

    Protein kinases are critical regulators of signaling cascades that control cellular proliferation, growth, survival, metabolism, migration, and invasion. Deregulation of kinase activity can lead to aberrant regulation of biological processes and to the onset of diseases, including cancer. In this review, we focus on oncogenic kinases and the signaling pathways they regulate that underpin tumor development. We highlight genomic biomarker-based precision medicine intervention strategies that match kinase inhibitors alone or in combination to mutationally activated kinase drivers, as well as progress towards implementation of these treatment strategies in the clinic. We also discuss the challenges for identification of novel protein kinase cancer drivers in the genomic era.

    See More

External Sources

  1. DOI: 10.3390/cancers11121972
  2. PMID: 31817861
  3. WOS: 000507382100149

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel